Tag Archives: longevity

Live From Miami Beach: A4M March Symposium Highlights 

Reporting live from Miami Beach, A4M is hosting hundreds of modern medicine’s leading game-changers this weekend at the March Symposium. We’re thrilled to be amongst such an inspiring crowd of renowned experts, pioneering researchers, and dedicated practitioners committed to elevating their knowledge, practice, and patient outcomes — a thriving community we are honored to be a part of.

This highly anticipated event marks the kickoff of A4M’s 2024 educational season — and it’s set to be groundbreaking. Featuring beloved returning programs and brand-new courses alike, the weekend’s diverse agenda empowers practitioners across every specialty and sector to level up their clinical toolkits and gain practical knowledge of emerging and in-demand therapeutic modalities.

From the best-selling BHRT Symposium to the inaugural iteration of State Of-Mind: A New Era in Psychedelic Medicine – a three-day immersive training in pioneering psychedelic-assisted therapies, transformative insights, and clinical pearls abound.

If you couldn’t join us this time, we want to ensure you don’t miss out on the wealth of cutting-edge learning taking place. Since we cannot teleport you to the Loews Miami Beach Hotel — although we wish we could — our on-site team has been sharing real-time updates for us to relay. Discover some key takeaways and event highlights from all the offerings on the agenda.

Continue reading

Mapping The Longevity Blueprint: Peptide Therapies

“The current use of peptides is everything you can think of. From antimicrobial, antioxidant, and anti-obesity uses, to hormone regulation, dyslipidemia, digestion, and cognitive performance enhancement. Virtually every bodily function you can think of utilizes peptides.” James LaValle, RPh, CCN, MT, DHM, DHPh, A4M Scientific Planning Committee and IPS Steering Committee Chair 

The mapping of the human longevity blueprint has launched a new era of research into peptide therapies for precision life extension. Groundbreaking peptide advances welcome a coming age in which the root causes of aging may be targeted, optimized, and potentially reversed – expanding the boundaries of the human lifespan. This paradigm shift represents a transition from reactive to proactive aging management, addressing fundamental age-related decline rather than downstream effects alone.

Today, there are over 90 FDA-approved peptide therapeutics with over 150 in clinical development and up to 600 undergoing preclinical trials. In medical practices across the globe, peptide therapies are being used to help treat cancer, infectious diseases, metabolic disorders, injuries, and much more.

Research continues to unveil the power of peptide therapies for disease management, performance optimization, and longevity strategies.

Continue reading

The top 5 most cited takeaways from LongevityFest 2023

5 Most-Cited Takeaways From LongevityFest 2023

Settling into the new year is the perfect time to focus on renewal, renewing our commitment to delivering excellent care and patient outcomes, and leveraging every beneficial tool at our disposal. What better way to kick off 2024 than by highlighting key learnings around longevity, healthy aging, and improving our healthspans presented at 2023’s biggest anti-aging medicine event.

Throughout the four days of LongevityFest 2023, more than 120 acclaimed experts delivered upwards of 200 forward-thinking, thought-provoking, and, beyond all, practically relevant educational sessions.

The agenda was an unforgettable learning extravaganza for longevity science and anti-aging medicine enthusiasts. From delving into the exclusive insights of Blue Zone pioneer Dan Buettner to learning about insulin-like growth factor 1 and other vital components of healthy aging, thousands of dedicated health professionals in attendance were enriched with the latest knowledge and developments in the field.

Continue reading